MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback